The agency announced new draft guidance to simplify biosimilarity studies and reduce clinical testing that it has deemed ...

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and ...

Lilly and NVIDIA’s supercomputer marks the world's first NVIDIA DGX SuperPOD with DGX B300 systems, and is powered by more than 1,000 B300 GPUs on a unified networking fabric, meaning communication ...

Marcel Botha, CEO of 10XBeta, discusses FDA’s new pilot authorization program for abbreviated new drug applications (ANDA) and what impact it will have on manufacturing and the supply chain.

Thermo Fisher Scientific is set to acquire Clario Holdings after entering a $8.8 billion definitive agreement, which includes ...

Eli Lilly and Walmart Pharmacy collaborate to offer Zepbound vials through LillyDirect, enhancing patient access and convenience. Patients with valid prescriptions can access Zepbound without ...

PE: What impact will DTC programs have on generic drug prices? O’Dell: Not much today, but generics are not completely immune ...

Marcel Botha, CEO of 10XBeta, discusses FDA’s new pilot authorization program for abbreviated new drug applications (ANDA) ...

In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to ...

Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license ...

Zag Bio announced the company’s launch with a $80 million financing round, which includes a recently closed Series A ...

The FDA has approved a new single-injection, once-monthly maintenance regimen for Eli Lilly’s Omvoh (mirikizumab-mrkz), ...